Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

1.

Treatment challenges in axial spondylarthritis and future directions.

Sieper J.

Curr Rheumatol Rep. 2013 Sep;15(9):356. doi: 10.1007/s11926-013-0356-9. Review.

PMID:
23888365
[PubMed - indexed for MEDLINE]
2.

Developments in therapies for spondyloarthritis.

Sieper J.

Nat Rev Rheumatol. 2012 Apr 10;8(5):280-7. doi: 10.1038/nrrheum.2012.40. Review.

PMID:
22487798
[PubMed - indexed for MEDLINE]
3.

Adalimumab for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis - a five-year update.

Poddubnyy D, Rudwaleit M.

Expert Opin Biol Ther. 2013 Nov;13(11):1599-611. doi: 10.1517/14712598.2013.839653. Epub 2013 Sep 27. Review.

PMID:
24074224
[PubMed - indexed for MEDLINE]
4.

Can we reduce the dosage of biologics in spondyloarthritis?

Olivieri I, D'Angelo S, Padula A, Leccese P, Nigro A, Palazzi C.

Autoimmun Rev. 2013 May;12(7):691-3. doi: 10.1016/j.autrev.2012.08.013. Epub 2012 Aug 23. Review.

PMID:
22940233
[PubMed - indexed for MEDLINE]
5.

Efficacy of anti-TNF in patients with spondyloarthritis in absence of any imaging sign.

Bisson-Vaivre A, Alcaix D, Zarnitsky C, Pueyo L, Daragon A, Lanfant-Weybel K, Dacher JN, Vittecoq O, Le Loët X, Goëb V.

Joint Bone Spine. 2013 May;80(3):280-6. doi: 10.1016/j.jbspin.2012.08.003. Epub 2012 Sep 26.

PMID:
23021158
[PubMed - indexed for MEDLINE]
6.

Therapeutic controversies in spondyloarthritis: nonsteroidal anti-inflammatory drugs.

Poddubnyy D, van der Heijde D.

Rheum Dis Clin North Am. 2012 Aug;38(3):601-11. doi: 10.1016/j.rdc.2012.08.005. Epub 2012 Sep 15. Review.

PMID:
23083758
[PubMed - indexed for MEDLINE]
7.

Current therapeutics for spondyloarthritis.

Toussirot É.

Expert Opin Pharmacother. 2011 Nov;12(16):2469-77. doi: 10.1517/14656566.2011.604313. Review.

PMID:
21988214
[PubMed - indexed for MEDLINE]
8.

Tumor necrosis factor alpha antagonists in the treatment of axial spondyloarthritis.

Braun J, Baraliakos X, Heldmann F, Kiltz U.

Expert Opin Investig Drugs. 2014 May;23(5):647-59. doi: 10.1517/13543784.2014.899351. Epub 2014 Mar 22. Review.

PMID:
24654630
[PubMed - indexed for MEDLINE]
9.

Appropriate management of axial spondyloarthritis.

LaSalle SP, Deodhar AA.

Curr Rheumatol Rep. 2007 Oct;9(5):375-82. Review.

PMID:
17915093
[PubMed - indexed for MEDLINE]
10.

[The pharmacotherapy of spondyloarthritis].

Curković B.

Reumatizam. 2011;58(2):65-8. Review. Croatian.

PMID:
22232952
[PubMed - indexed for MEDLINE]
11.

How important is early therapy in axial spondyloarthritis?

Sieper J, Braun J.

Rheum Dis Clin North Am. 2012 Aug;38(3):635-42. doi: 10.1016/j.rdc.2012.08.001. Epub 2012 Sep 13. Review.

PMID:
23083760
[PubMed - indexed for MEDLINE]
12.

Update on biologic therapy in the management of axial spondyloarthritis.

Heldmann F, Dybowski F, Saracbasi-Zender E, Fendler C, Braun J.

Curr Rheumatol Rep. 2010 Oct;12(5):325-31. doi: 10.1007/s11926-010-0125-y.

PMID:
20665135
[PubMed - indexed for MEDLINE]
13.

Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.

Ciurea A, Scherer A, Exer P, Bernhard J, Dudler J, Beyeler B, Kissling R, Stekhoven D, Rufibach K, Tamborrini G, Weiss B, Müller R, Nissen MJ, Michel BA, van der Heijde D, Dougados M, Boonen A, Weber U; Rheumatologists of the Swiss Clinical Quality Management Program for Axial Spondyloarthritis.

Arthritis Rheum. 2013 Dec;65(12):3096-106. doi: 10.1002/art.38140.

PMID:
23983141
[PubMed - indexed for MEDLINE]
Free Article
14.

Biologic therapies for spondyloarthritis: what is new?

Baraliakos X, Braun J.

Curr Rheumatol Rep. 2012 Oct;14(5):422-7. doi: 10.1007/s11926-012-0282-2. Review.

PMID:
22855297
[PubMed - indexed for MEDLINE]
15.

[Diagnosis and therapy of axial spondyloarthritis including ankylosing spondylitis (Bechterew's disease)].

Poddubnyy D, Sieper J.

Orthopade. 2012 Jul;41(7):533-8. doi: 10.1007/s00132-012-1926-7. German.

PMID:
22744304
[PubMed - indexed for MEDLINE]
16.

Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial.

Song IH, Weiß A, Hermann KG, Haibel H, Althoff CE, Poddubnyy D, Listing J, Lange E, Freundlich B, Rudwaleit M, Sieper J.

Ann Rheum Dis. 2013 Jun;72(6):823-5. doi: 10.1136/annrheumdis-2012-202389. Epub 2012 Nov 21.

PMID:
23172749
[PubMed - indexed for MEDLINE]
17.

Opinion: Perspectives on imaging in axial spondyloarthritis.

Baraliakos X, Braun J.

Nat Rev Rheumatol. 2013 Aug;9(8):498-502. doi: 10.1038/nrrheum.2013.83. Epub 2013 Jun 18. Review.

PMID:
23774899
[PubMed - indexed for MEDLINE]
18.

Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1).

Sieper J, van der Heijde D, Dougados M, Mease PJ, Maksymowych WP, Brown MA, Arora V, Pangan AL.

Ann Rheum Dis. 2013 Jun;72(6):815-22. doi: 10.1136/annrheumdis-2012-201766. Epub 2012 Jul 7.

PMID:
22772328
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Certolizumab pegol in axial spondyloarthritis.

Song IH, Rudwaleit M.

Expert Rev Clin Immunol. 2013 Dec;9(12):1161-72. doi: 10.1586/1744666X.2013.858859. Review.

PMID:
24215406
[PubMed - indexed for MEDLINE]
20.

Axial spondyloarthritis: thoughts about nomenclature and treatment targets.

Braun J.

Clin Exp Rheumatol. 2012 Jul-Aug;30(4 Suppl 73):S132-5. Epub 2012 Oct 18.

PMID:
23079005
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk